New York City/Geneva (December 9, 2021) – The new Tuberculosis Research Funding Trends,2005–2020 report from Treatment Action Group (TAG) and the Stop TB Partnership (STBP) finds that global funding for TB research totaled US$915 million in 2020 – less than half the goal of US$2 billion set forth by participating country governments at the 2018 United Nations High-Level Meeting on TB.
The report presents new data on 2020 funding for TB research and development (R&D) and analyzes trends in investment since 2005. Despite the toll TB takes around the world, TB funding has been flat since 2018, and in 2020 TB received less than 1% of the amount invested in COVID-19 R&D.
“The mobilization of over US$100 billion for COVID-19 research and development in the first 11 months of the pandemic shows us just how powerful a coordinated effort against a disease can be,” noted Dr. Lucica Ditiu, Executive Director of the Stop TB Partnership. “We can and must harness this impressive commitment to global health toward the fight to end TB.”
View the full Press Release announcing the report here.
Key report resources
Source : Stop TB Partnership
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.